Filing Details

Accession Number:
0001127602-10-013460
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-07 13:00:00
Reporting Period:
2010-05-06
Filing Date:
2010-05-07
Accepted Time:
2010-05-07 16:25:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106578 A Martine Rothblatt Ceo Yes Yes No No
Transaction Summary
Sold: 20,015 shares Avg. Price: $53.08 Total Value: $1,062,422.94
Number of Shares After Transactions: 590,393 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-06 8,000 $21.80 8,765 No 4 M Direct
Common Stock Disposition 2010-05-06 8,000 $53.29 765 No 4 S Direct
Common Stock Disposition 2010-05-06 4,391 $52.95 598,017 No 4 S Indirect By Trusts
Common Stock Disposition 2010-05-06 5,279 $52.94 592,738 No 4 S Indirect By Trusts
Common Stock Disposition 2010-05-06 2,345 $52.94 590,393 No 4 S Indirect By Trusts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Indirect By Trusts
No 4 S Indirect By Trusts
No 4 S Indirect By Trusts
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2010-05-06 8,000 $0.00 8,000 $21.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
98,828 2005-01-20 2015-01-20 No 4 M Direct
Footnotes
  1. Shares held by the reporting person in GRATs and PMTs.
  2. This exercise and sale of 8,000 shares is pursuant to the 10b5-1 Plan adopted by the reporting person on August 21, 2006.
  3. This sale of shares is pursuant to the 10b5-1 Plan adopted by the reporting person on February 25, 2010.
  4. This sale of shares is pursuant to a 10b5-1 Plan adopted by the reporting person on February 25, 2010.